3.4. Effect of MED-01 on Vaginal Symptoms
pain
The results of the symptom questionnaire evaluation demonstrated that vaginal discharges and dysuria pain were significantly reduced in the MED-01-intake group after 6 and 12 weeks of intake compared with that at the baseline (